Ironwood Pharmaceuticals, Inc.’s ( IRWD ) third-quarter 2012 earnings of 42 cents per share compared favorably with the year-ago loss of 21 cents per share and the Zacks Consensus
Boston Scientific ( BSX ) reported a net loss of $725 million or 52 cents per share in the third quarter of 2012, a disappointment from net income of $142 million or earnings per share